Baseline neutrophil‐lymphocyte ratio is associated with survival for infant living donor liver transplantation for biliary atresia. (3rd December 2020)

• Record Type: Journal Article
• Authors: Meng, Xiao‐Yan; Guo, Xin‐gang; Wang, Hong‐Qian; Pan, Zhi‐Ying; Lu, Yu‐Gang; Yu, Wei‐Feng
• Is Part Of: Pediatric transplantation. Volume 25:Number 3(2021)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2020-12-03
• Subjects: infants -- living donor liver transplantation -- neutrophil‐lymphocyte ratio -- recipient and graft survival -- risk factors; Transplantation of organs, tissues, etc. in children -- Periodicals; 617.95408305
• DOI: 10.1111/petr.13933
• Languages: English
• ISSNs: 1397-3142

Abstract

Abstract: Living donor liver transplantation (LDLT) in infants for congenital biliary atresia (BA) poses various challenges nowadays. We aim to investigate independent preoperative risk factors for LDLT in infants. We retrospectively analyzed medical records of infant patients who underwent LDLT surgery for BA from 1 July 2014 to 31 December 2016. Cox regression was used to explore risk factors. The Kaplan‐Meier method was used to calculate the recipient and graft survival, and subgroup analysis was then applied according to the risk factors. Independent t test or Mann‐Whitney U test was applied for comparison of certain factors between survival patients and death. A total of 345 infant LDLT for BA were included in the analysis. In the multivariate Cox‐regression model, 3 factors were determined as independent risk factors for recipient and graft survival, there were neutrophil‐lymphocyte ratio (NLR), pediatric end‐stage liver disease (PELD), and recipient age. The HR (95% CI) of baseline NLR for recipient and graft survival were 1.25 (1.12‐1.38) and 1.25 (1.13‐1.39), with all P < .0001. Kaplan‐Meier curves for NLR using different cut‐offs (1.5; 1, 2) suggested that higher baseline NLR was significantly associated with recipient and graft survival. The subgroup analysis indicated that for infants with elevated NLR, the recipient survival was significantly lower when their age >6 months or PELD >20. Our results indicate that infants with higher baseline NLR value may have lower survival rate 3 years after transplantation. Further investigations about broaden the application of pre‐ and post‐transplant NLR to guide nutrition intervention and immunosuppression therapy are necessary.